Exhibition and Partnership
Join the ESMINT Congress in 2024 and reach an audience composed of the best-known specialists from around the globe.
Exhibition and Partnership Opportunities
Please contact the congress organisation for further information on becoming an exhibitor and/or partner of the ESMINT Congress 2024:
ESMINT Congress
c/o Congrex Switzerland Ltd.
Reinacherstrasse 131
4053 Basel / Switzerland
+41 61 686 77 96
+41 61 686 77 88
industry.esmint@congrex.com
Opportunity for Start-up companies
The Start-Up Alley offers start-ups a unique opportunity to showcase their presence at the ESMINT Congress and leverage the cutting-edge science and unmatched networking opportunities it provides.
MedTech Europe Code of Ethical Business Practice
The 16th ESMINT Congress 2024 – the 16th Congress of the European Society of Minimally Invasive Neurological Therapy – is compliant with the MedTech Europe Code of Ethical Business Practice.
Kindly refer to the MedTech Europe listing.
Educational Grants
Educational grants are a wonderful opportunity to show your company’s support for the congress by promoting the attendance of physicians from both Europe and overseas.
The new MedTech Europe Ethical charter came into force from January 1, 2018 and in effect, direct sponsorship of Health Care Professionals (HCPs) by MedTech member companies is prohibited. As a result, these companies will have to channel their support through trusted partners such as Health Care Organisations (HCOs: i.e. hospitals, clinics, medical institutions), the ESMINT Society or the PCO (Professional Congress Organiser). Moreover, Congrex Switzerland, the PCO of the ESMINT Congress in Marseille, is a MedTech Europe Trusted Partner and is committed to comply with MedTech Europe’s ethical standards.
The ESMINT Society, in adhesion to the MedTech Europe Code of Ethical Business Practice, is seeking industry sponsorship to financially support Health Care Professionals in the field of interventional neuroradiology along with vascular neurology and neurosurgery to attend our Congress of the European Society of Minimally Invasive Neurological Therapy.
Industry Partners
Platinum Level
Gold Level
Industry Symposia @ ESMINT Congress 2024
Wednesday, 4 Sep 2024
Room: Main Lecture Hall
| Time | Session | Speaker |
|---|---|---|
| 09:45–10:00 | INDUSTRY SYMPOSIUM I Wallaby Phenox |
|
| 09:45 – 09:52 | Expanding Flow Diverter usage : p64MW & p48MW in the treatment of bifurcation aneurysms | Laurent SPELLE, France |
| 09:52 – 10:00 | Use of p64-MW and p48-MW in the treatment of bifurcation aneurysms | Laurent SPELLE, France |
| 12:30–13:00 | INDUSTRY SYMPOSIUM II MicroVention |
Alessandra BIONDI, France |
| 14:00–14:30 | INDUSTRY SYMPOSIUM III BALT |
|
| 14:00 – 14:15 | Leo baby stents for complex cerebral aneurysms | Arnd DÖRFLER, Germany |
| 14:15 – 14:30 | Silk Vista & Silk Vista Baby: 1-year results of FIRST study | Mario MARTINEZ GALDAMEZ, Spain |
Thursday, 5 Sep 2024
Room: Main Lecture Hall
| Time | Session | Speaker |
|---|---|---|
| 09:45–10:00 | INDUSTRY SYMPOSIUM IV Cerenovus |
|
| 09:45 – 09:51 | CERENOVUS EMBOGUARD™ Balloon Guide Catheter, designed to meet the challenges of distal anatomy. | Mahmood MIRZA, Ireland |
| 09:51 – 10:00 | Clinical Experience with EMBOGUARD™. | Vitor MENDES PEREIRA, Canada |
| 12:30–13:00 | INDUSTRY SYMPOSIUM V Stryker |
Riitta RAUTIO, Finland |
| 12:30 – 12:40 | Target Tetra ™ Detachable Coil: Reshaping Possibilities in Aneurysm Treatment. | Jean-Christophe GENTRIC, France |
| 12:40 – 12:50 | Data and Innovation on Acute Ischemic Stroke. | Markus MOEHLENBRUCH, Germany |
| 12:50 – 13:00 | Surpass Evolve™ Flow Diverter SEASE clinical Results and Learnings. | Mario MARTINEZ GALDAMEZ, Spain |
| 14:00–14:30 | INDUSTRY SYMPOSIUM VI Medtronic |
Jens FIEHLER, Germany |
| 14:00 – 14:15 | Elevating Clinical Data Standards: VANTAGE Insights. | Alejandro TOMASELLO, Spain |
| 14:15 – 14:30 | INSPIR’ING Thrombectomy Techniques. | Pasquale MORDASINI, Switzerland |
Friday, 6 Sep 2024
Room: Main Lecture Hall
| Time | Session | Speaker |
|---|---|---|
| 09:45–10:00 | INDUSTRY SYMPOSIUM VII Siemens Healthineers |
Markus HOLTMANNSPÖTTER, Germany |
| 09:45 – 10:00 | Advancing Aneurysm treatment with ARTIS icono. | Markus HOLTMANNSPÖTTER, Germany |
| 10:30–10:45 | INDUSTRY SYMPOSIUM VIII Penumbra |
Vincent COSTALAT, France |
| 10:30 – 10:45 | Expanding the options to open the vessel: Customised Stroke Solutions. | Vincent COSTALAT, France |
Start-up Sessions @ ESMINT Congress 2024
Wednesday, 4 Sep 2024
Room: Main Lecture Hall
| Time | Session | Speaker |
|---|---|---|
| 08:45–09:15 | START-UP SESSION Chairs: Elisa CICERI, Italy Paolo MACHI, Switzerland |
|
| 08:45-08:52 | Artiria’s Innovative Guidewire: Journey from Concept to First-in-Human trial | |
| 08:52-08:59 | LEMER PAX – Changing the paradigm in interventional medicine with introduction of NOVASHELL | |
| 08:59-09:06 | Oxford Heartbeat Ltd. – How to demonstrate reliability and impact of AI? Precision Surgery with PreSize Neurovascular medical device software and its level of evidence | |
| 09:06-09:13 | Sonorous Neurovascular: Venous Sinus Stenting to treat debilitating Pulsatile Tinnitus |